Notably, there was a large variability in the results of the included trials, with 2 demonstrating lowered [71,85], 2 indifferent [41,53] and 1 elevated [64] erythrocyte SOD activity in the CF group versus controls. The gene discussed is SOD1; the disease is cystic fibrosis.